SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-019921
Filing Date
2020-04-30
Accepted
2020-04-30 06:08:58
Documents
63
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q aveo-10q_20200331.htm 10-Q 2416034
2 EX-10.2 aveo-ex102_224.htm EX-10.2 105814
3 EX-31.1 aveo-ex311_9.htm EX-31.1 16533
4 EX-31.2 aveo-ex312_6.htm EX-31.2 16528
5 EX-32.1 aveo-ex321_8.htm EX-32.1 4471
6 EX-32.2 aveo-ex322_7.htm EX-32.2 4462
  Complete submission text file 0001564590-20-019921.txt   10793138

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT aveo-20200331.xml EX-101.INS 2635064
8 XBRL TAXONOMY EXTENSION SCHEMA aveo-20200331.xsd EX-101.SCH 69283
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aveo-20200331_cal.xml EX-101.CAL 49989
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aveo-20200331_def.xml EX-101.DEF 279688
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE aveo-20200331_lab.xml EX-101.LAB 556773
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aveo-20200331_pre.xml EX-101.PRE 432086
Mailing Address 30 WINTER STREET BOSTON MA 02108
Business Address 30 WINTER STREET BOSTON MA 02108 617-448-3566
AVEO PHARMACEUTICALS, INC. (Filer) CIK: 0001325879 (see all company filings)

IRS No.: 043581650 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34655 | Film No.: 20832984
SIC: 2834 Pharmaceutical Preparations